Tag Archives: Japan

Planning Beyond the Petri Dish: A Pfizer Case Study

By William Looney | Published: June 29, 2011
Pfizer’s crizotinib development program combined organization, art, and science— and a large dose of unforeseen risk. The path to commercializing a breakthrough discovery is rarely a linear process. The orderly rationale of the scientific method is often overtaken by the random artistry of passion, personality, business culture, and sheer luck. Each plays a [...]
Posted in Emerging Markets, Global, R&D | Also tagged , , , , , , | Leave a comment

Industry Reactions to Japan Earthquake Crisis

By Julian Upton | Published: March 16, 2011
As a dazed Japan copes with the aftermath of the Tohoku earthquake, Japanese pharma companies have been quick to offer donations of both money and medical supplies and help with aid efforts. Takeda has pledged 300m Japanese Yen ($3.6m) to the Japanese Red Cross Society to help the emergency relief fund, as well as offering [...]
Posted in Global | Also tagged , , , , , | Leave a comment

Astellas and OSI Come Together

By Oriana Schwindt | Published: May 19, 2010
The months-long saga is finally over: Astellas’ enhanced offer of $57.50 a share—around $4 billion—has finally netted it Melville, NY-based OSI Pharmaceuticals. The Japan-based pharma first extended an acquisition offer of $52 per share ($3.5 billion) to OSI on March 1, only to be met with a resounding “Nay” from the board, which said $52 [...]
Posted in Deals, News, Strategy | Also tagged , , , , , | Leave a comment